Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Ipsen Pauses Palovarotene Program After Interim Analysis Finds Phase 3 Trial Unlikely to Meet its Primary Endpoint
- Roche’s Tecentriq Fails to Meet Primary Endpoint in Phase 3 Study in Patients with Muscle-Invasive Urothelial Cancer
- Exelixis Announces Results for Combination of Cabozantinib and Nivolumab with or without Ipilimumab in Advanced Hepatocellular Carcinoma
- FDA Grants Accelerated Approval to Epizyme’s Tazverik for Treatment of Patients with Epithelioid Sarcoma
- Genentech’s Risdiplam Meets Primary Endpoint in Pivotal Trial in Infants with Type 1 Spinal Muscular Atrophy
- Sanofi Completes Acquisition of Synthorx, Expanding its Oncology and Immunology Business
- New Research Shows EarlySign’s AI Solution Can Identify Prediabetic Patients at High Risk of Developing Diabetes
- Akcea and Ionis Report Positive Topline Results from Phase 2 Study of AKCEA-APOCIII-L Rx
- Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases
- FDA Approves Horizon’s Tepezza for Treatment of Thyroid Eye Disease